JPTCCM
GILD icon

J.P. Turner & Co Capital Management’s Gilead Sciences GILD Stock Holding History

J.P. Turner & Co Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$367K Sell
3,843
-3,767
-50% -$418K 0.38% 92
2015
Q2 		$886K Buy
7,610
+1,570
+26% +$172K 0.69% 43
2015
Q1 		$596K Buy
6,040
+3,914
+184% +$397K 0.55% 56
2014
Q4 		$201K Buy
+2,126
New +$220K 0.19% 167

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

J.P. Turner & Co Capital Management's GILD Position: Q3 2015 in Review

J.P. Turner & Co Capital Management reduced its Gilead Sciences (GILD) stake by 50% in Q3 2015, selling an estimated $418K and leaving 3,843 shares worth $367K. The position accounts for 0.38% of the portfolio, ranked #92.

J.P. Turner & Co Capital Management first reported a position in GILD in Q4 2014 and has held it in 4 quarters since. The position peaked at $886K in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • J.P. Turner & Co Capital Management held 3,843 shares of Gilead Sciences worth $367K as of Q3 2015.
  • J.P. Turner & Co Capital Management sold 3,767 Gilead Sciences shares in Q3 2015, an estimated $418K.
  • Gilead Sciences made up 0.38% of J.P. Turner & Co Capital Management's portfolio in Q3 2015, its #92 holding.
  • J.P. Turner & Co Capital Management first reported a position in Gilead Sciences in Q4 2014 and has held it in 4 quarters since.
  • J.P. Turner & Co Capital Management's Gilead Sciences position peaked at $886K in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on J.P. Turner & Co Capital Management's 13F filing for Q3 2015, filed 4 Nov 2015.